Literature DB >> 21523347

Biphasic dopamine regulation in mesoaccumbens pathway in response to non-contingent binge and escalating methamphetamine regimens in the Wistar rat.

Courtney M Keller1, Michael F Salvatore, Brandon S Pruett, Glenn F Guerin, Nicholas E Goeders.   

Abstract

RATIONALE: Methamphetamine (MA) increases extracellular dopamine (DA) and at chronic high doses induces toxicity as indicated by decreased expression of tyrosine hydroxylase (TH) and dopamine transporter (DAT). Notably, rats will self-administer MA in escalating quantities producing such toxicity. However, the impact of MA at sub-toxic doses on DA regulation is not well established.
OBJECTIVE: The temporal dynamics of DA regulation following cessation of sub-toxic escalating and binge doses of non-contingent MA were investigated as changes therein may be associated with escalation of MA intake.
MATERIALS AND METHODS: MA was administered 3×/day using an established 14-day escalating-dose regimen (0.1-4.0 mg/kg) or a single-day binge-style administration (3 × 4 mg/kg). DA tissue content, DA turnover, TH protein, TH phosphorylation, DAT, and vesicular monoamine transporter 2 were measured in nigrostriatal and mesoaccumbens pathways 48 h and 2 weeks after MA cessation.
RESULTS: Changes in striatal DA regulation were limited to increased DA turnover. However, in the mesoaccumbens pathway, escalating MA had biphasic effects. DA was increased in ventral tegmental area (VTA) and decreased in nucleus accumbens at 48 h post-MA while the reverse was seen at 2 weeks. These changes were matched by similar changes in TH protein and, in the VTA, by changes in DAT.
CONCLUSION: Escalation of MA intake produces both transient and long-lasting effects upon DA, TH, and DAT in the mesoaccumbens pathway. The eventual decrease of DA in the VTA is speculated to contribute to craving for MA and, thus, may be associated with MA escalation and resulting dopaminergic toxicity.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21523347     DOI: 10.1007/s00213-011-2301-9

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  69 in total

1.  Nucleus accumbens-derived glial cell line-derived neurotrophic factor is a retrograde enhancer of dopaminergic tone in the mesocorticolimbic system.

Authors:  Jun Wang; Sebastien Carnicella; Somayeh Ahmadiantehrani; Dao-Yao He; Segev Barak; Viktor Kharazia; Sami Ben Hamida; Agustin Zapata; Toni S Shippenberg; Dorit Ron
Journal:  J Neurosci       Date:  2010-10-27       Impact factor: 6.167

Review 2.  Altered vesicular dopamine storage in Parkinson's disease: a premature demise.

Authors:  W Michael Caudle; Rebecca E Colebrooke; Piers C Emson; Gary W Miller
Journal:  Trends Neurosci       Date:  2008-05-09       Impact factor: 13.837

3.  Vasoactive intestinal peptide stimulates catecholamine biosynthesis in isolated adrenal chromaffin cells: evidence for a cyclic AMP-dependent phosphorylation and activation of tyrosine hydroxylase.

Authors:  J C Waymire; G L Craviso; K Lichteig; J P Johnston; C Baldwin; R E Zigmond
Journal:  J Neurochem       Date:  1991-10       Impact factor: 5.372

4.  Ultrastructural localization of the vesicular monoamine transporter-2 in midbrain dopaminergic neurons: potential sites for somatodendritic storage and release of dopamine.

Authors:  M J Nirenberg; J Chan; Y Liu; R H Edwards; V M Pickel
Journal:  J Neurosci       Date:  1996-07-01       Impact factor: 6.167

5.  Methamphetamine-induced dopaminergic neurotoxicity is regulated by quinone-formation-related molecules.

Authors:  Ikuko Miyazaki; Masato Asanuma; Francisco J Diaz-Corrales; Masaya Fukuda; Kiyoyuki Kitaichi; Ko Miyoshi; Norio Ogawa
Journal:  FASEB J       Date:  2006-01-10       Impact factor: 5.191

6.  Depolarization-stimulated catecholamine biosynthesis: involvement of protein kinases and tyrosine hydroxylase phosphorylation sites in situ.

Authors:  M F Salvatore; J C Waymire; J W Haycock
Journal:  J Neurochem       Date:  2001-10       Impact factor: 5.372

7.  Reversal of prolonged dopamine inhibition of dopaminergic neurons of the ventral tegmental area.

Authors:  Sudarat Nimitvilai; Mark S Brodie
Journal:  J Pharmacol Exp Ther       Date:  2010-02-17       Impact factor: 4.030

8.  Striatal GDNF administration increases tyrosine hydroxylase phosphorylation in the rat striatum and substantia nigra.

Authors:  Michael F Salvatore; Jin-Lu Zhang; Delia M Large; Patsy E Wilson; Clelland R Gash; Theresa Currier Thomas; John W Haycock; Guoying Bing; John A Stanford; Don M Gash; Greg A Gerhardt
Journal:  J Neurochem       Date:  2004-07       Impact factor: 5.372

Review 9.  Regulation of drug-taking and -seeking behaviors by neuroadaptations in the mesolimbic dopamine system.

Authors:  David W Self
Journal:  Neuropharmacology       Date:  2004       Impact factor: 5.250

10.  Human methamphetamine pharmacokinetics simulated in the rat: behavioral and neurochemical effects of a 72-h binge.

Authors:  Ronald Kuczenski; David S Segal; William P Melega; Goran Lacan; Stanley J McCunney
Journal:  Neuropsychopharmacology       Date:  2009-07-01       Impact factor: 7.853

View more
  11 in total

1.  Chronic wheel running-induced reduction of extinction and reinstatement of methamphetamine seeking in methamphetamine dependent rats is associated with reduced number of periaqueductal gray dopamine neurons.

Authors:  Jeffery C Sobieraj; Airee Kim; McKenzie J Fannon; Chitra D Mandyam
Journal:  Brain Struct Funct       Date:  2014-10-02       Impact factor: 3.270

2.  Effects of diet and insulin on dopamine transporter activity and expression in rat caudate-putamen, nucleus accumbens, and midbrain.

Authors:  Kymry T Jones; Catherine Woods; Juan Zhen; Tamara Antonio; Kenneth D Carr; Maarten E A Reith
Journal:  J Neurochem       Date:  2017-01-31       Impact factor: 5.372

3.  Prolonged increase in ser31 tyrosine hydroxylase phosphorylation in substantia nigra following cessation of chronic methamphetamine.

Authors:  Michael F Salvatore; Vicki A Nejtek; Habibeh Khoshbouei
Journal:  Neurotoxicology       Date:  2018-05-18       Impact factor: 4.294

4.  Comprehensive profiling of dopamine regulation in substantia nigra and ventral tegmental area.

Authors:  Michael F Salvatore; Brandon S Pruett; Charles Dempsey; Victoria Fields
Journal:  J Vis Exp       Date:  2012-08-10       Impact factor: 1.355

5.  Aggregated single-walled carbon nanotubes attenuate the behavioural and neurochemical effects of methamphetamine in mice.

Authors:  Xue Xue; Jing-Yu Yang; Yi He; Li-Rong Wang; Ping Liu; Li-Sha Yu; Guo-Hua Bi; Ming-Ming Zhu; Yue-Yang Liu; Rong-Wu Xiang; Xiao-Ting Yang; Xin-Yu Fan; Xiao-Min Wang; Jia Qi; Hong-Jie Zhang; Tuo Wei; Wei Cui; Guang-Lu Ge; Zheng-Xiong Xi; Chun-Fu Wu; Xing-Jie Liang
Journal:  Nat Nanotechnol       Date:  2016-03-14       Impact factor: 39.213

6.  Chronic methamphetamine exposure produces a delayed, long-lasting memory deficit.

Authors:  Ashley North; Jarod Swant; Michael F Salvatore; Joyonna Gamble-George; Petra Prins; Brittany Butler; Mukul K Mittal; Rebecca Heltsley; John T Clark; Habibeh Khoshbouei
Journal:  Synapse       Date:  2013-02-08       Impact factor: 2.562

7.  Regulation of Tyrosine Hydroxylase Expression and Phosphorylation in Dopamine Transporter-Deficient Mice.

Authors:  Michael F Salvatore; Erin S Calipari; Sara R Jones
Journal:  ACS Chem Neurosci       Date:  2016-05-10       Impact factor: 4.418

8.  Dichotomy of tyrosine hydroxylase and dopamine regulation between somatodendritic and terminal field areas of nigrostriatal and mesoaccumbens pathways.

Authors:  Michael F Salvatore; Brandon S Pruett
Journal:  PLoS One       Date:  2012-01-05       Impact factor: 3.240

9.  The Effect of Chronic Methamphetamine Exposure on the Hippocampal and Olfactory Bulb Neuroproteomes of Rats.

Authors:  Rui Zhu; Tianjiao Yang; Firas Kobeissy; Tarek H Mouhieddine; Mohamad Raad; Amaly Nokkari; Mark S Gold; Kevin K Wang; Yehia Mechref
Journal:  PLoS One       Date:  2016-04-15       Impact factor: 3.240

10.  Dopamine transporter loss in 6-OHDA Parkinson's model is unmet by parallel reduction in dopamine uptake.

Authors:  Tanya Chotibut; Deana M Apple; Rebecca Jefferis; Michael F Salvatore
Journal:  PLoS One       Date:  2012-12-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.